The value relevance of financial statements in the venture capital market

Accounting Review

Volumn 80, Issue 2, 2005, Pages 613-648

  Hand, John R M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Biotechnology; Financial statements; Firm maturity; Investment opportunities; Nonfinancial statement information; Private equity; Value relevance; Venture capital

Indexed keywords

EID: 18944369743     PISSN: 00014826     EISSN: None     Source Type: Journal    
DOI: 10.2308/accr.2005.80.2.613     Document Type: Article

References (68)

1. Adam, T., and V. K. Goyal. 2003. The investment opportunity set and its proxy variables: Theory and evidence. Working paper, Hong Kong University of Science & Technology.
2. Amir, E., and B. Lev. 1996. Value relevance of nonfinancial information: The wireless communications industry. Journal of Accounting & Economics 22: 3-30.
3. Barth, M. E., W. H. Beaver, and W. R. Landsman. 1998. Relative valuation roles of equity book value and net income as a function of financial health. Journal of Accounting & Economics 25: 1- 34.
4. _, _, and _. 2001. The relevance of the value relevance literature for financial accounting standard setting: Another view. Journal of Accounting & Economics 31: 77-104.
5. Beatty, R., S. Riffe, and R. Thompson. 2001. The log-linear form of stock value models based on accounting information. Working paper, Southern Methodist University.
6. Berger, P. G., E. Ofek, and I. Swary. 1996. Investor valuation of the abandonment option. Journal of Financial Economics 42: 257-287.
7. Black, E. L. 1998. Life cycle impacts on the incremental value relevance of earnings and cash flow measures. Journal of Financial Statement Analysis Fall: 40-56.
8. Brav, A., and P. A. Gompers. 1997. Myth or reality? The long-run underperformance of initial public offerings: Evidence from venture- and nonventure-capital-backed companies. Journal of Finance 52: 1791-1822.
9. Brown, S., K. Lo, and T. Lys. 1999. Use of R-squared in accounting research: Measuring changes in value relevance over the last four decades. Journal of Accounting & Economics 28: 83-115.
10. _, _, and _. 2002. Erratum to "Use of R-squared in accounting research: Measuring changes in value relevance over the last four decades." Journal of Accounting & Economics 33: 141.
11. Cochrane, J. H. 2004. The risk and return of venture capital. Working paper, University of Chicago.
12. Collins, D. W., E. L. Maydew, and I. S. Weiss. 1997. Changes in the value relevance of earnings and book values over the past forty years. Journal of Accounting & Economics 24: 39-67.
13. Darby, M. R., Q. Liu, and L. G. Zucker. 1999. Stars and stakes: The effect of intellectual human capital on the level and variability of high-tech firms' market values. Working paper, University of California, Los Angeles.
14. Davidson, R., and J. G. MacKinnon. 1993. Estimation and Inference in Econometrics. Oxford, U.K.: Oxford University Press.
15. Deng, Z., B. Lev, and F. Narin. 1999. Science and technology as predictors of stock performance. Financial Analysts Journal 55 (5): 20-32.
16. Ely, K., P. Simko, and L. G. Thomas. 2003. The usefulness of biotechnology firms' drug development status in the evaluation of research and development costs. Journal of Accounting, Auditing and Finance 18: 163-196.
17. Fenn, G. W., N. Liang, and S. Prowse. 1995. The Economics of the Private Equity Market. Washington, D.C.: Board of Governors of the Federal Reserve System.
18. Financial Accounting Standards Board (FASB). 1978. Statement of Financial Accounting Concepts No. 1. Norwalk, CT: FASB.
19. Gaver, J. J., and K. M. Gaver. 1993. Additional evidence on the association between the investment opportunity set and corporate financing, dividend and compensation policies. Journal of Accounting & Economics 16: 125-160.
20. Gompers, P. A. 1995. Optimal investment, monitoring, and the staging of venture capital. Journal of Finance 50: 1461-1490.
21. _, and J. Lerner. 1999. An analysis of compensation in the U.S. venture capital partnership. Journal of Financial Economics 51: 3-44.
22. _, and _. 2000a. The Venture Capital Cycle. Cambridge, MA: MIT Press.
23. _, and _. 2000b. Money chasing deals? The impact of fund inflows on the valuation of private equity investments. Journal of Financial Economics 55: 281-325.
24. 2s and additional evidence on value relevance changes over time. Working paper, Carnegie Mellon University.
25. Guo, R., B. Lev, and N. Zhou. 2004. Competitive costs of disclosure by biotech IPOs. Journal of Accounting Research 42 (2): 319-355.
26. Hall, B. H. 1993. The stock market's valuation of research and development investment during the 1980s. American Economic Review 83: 259-264.
27. _. 2000. Innovation and market value. In Productivity, Innovation and Economic Performance, edited by R. Barrell, G. Mason, and M. O'Mahoney. Cambridge, U.K.: Cambridge University Press.
28. _, A. Jaffe, and M. Trajtenberg. 2001. Market value and patent citations: A first look. NBER Working Paper No. 7741. Cambridge, MA: National Bureau of Economic Research.
29. Hand, J. R. M. 2003. Profits, losses and the nonlinear pricing of Internet stocks. In Intangible Assets: Values, Measures, and Risks, edited by J. R. M. Hand, and B. Lev. Oxford, U.K.: Oxford University Press.
30. _. 2004. The market valuation of biotechnology firms and biotechnology R&D. In Venture Capital Contracting and the Valuation of High-Technology Firms, edited by J. McCahery, and L. Renneboog. Oxford, U.K.: Oxford University Press.
31. Hansen, L. P. 1982. Large sample properties of generalized method of moments estimators. Econometrica 50: 1029-1054.
32. Heckman, J. J. 1976. The common structure of statistical models of truncation, sample selection and limited dependent variables and a simple estimator for such models. Annals of Economic and Social Measurement 5: 475-492.
33. Houlihan Valuation Advisors/VentureOne. 1998. The pricing of successful venture-backed high-tech and life-science companies. Journal of Business Venturing 13: 331-351.
34. Ittner, C., and D. Larcker. 1998. Are nonfinancial measures leading indicators of financial performance? An analysis of customer satisfaction. Journal of Accounting Research 6: 205-238.
35. Joos, P. 2002. Explaining cross-sectional differences in market-to-book ratios in the pharmaceutical industry. Working paper, University of Rochester.
36. Kaplan, S. N., and R. S. Ruback. 1995. The valuation of cash flow forecasts: An empirical analysis. Journal of Finance 50: 1059-1093.
37. _, and P. Stromberg. 2003. Financial contracting meets the real world: An empirical analysis of venture capital contracts. Review of Economics Studies 70: 281-315.
38. _, and _. 2004. Characteristics, contracts, and actions: Evidence from venture capitalist analyses. Journal of Finance 59 (5): 2177-2210.
39. Kothari, S. P. 2001. Capital markets research in accounting. Journal of Accounting & Economics 31: 105-231.
40. Lerner, J. 1994a. The importance of patent scope: An empirical analysis. Rand Journal of Economics 25: 319-333.
41. _. 1994b. Venture capitalists and the decision to go public. Journal of Financial Economics 35: 293-316.
42. Lev, B., and P. Zarowin. 1999. The boundaries of financial reporting and how to extend them. Journal of Accounting Research 37: 353-385.
43. _. 2001. Intangibles: Management, Measurement, and Reporting. Washington, D.C.: Brookings Institution Press.
44. Maddala, G. S. 1977. Econometrics. New York, NY: McGraw-Hill.
45. Miller, M. H., and F. Modigliani. 1961. Dividend policy, growth and the valuation of shares. Journal of Business 34: 411-433.
46. Myers, S. 1977. Determinants of corporate borrowing. Journal of Financial Economics 5: 147-175.
47. Newey, W. K., and K. D. West. 1987. A simple, positive semi-definite, heteroskedasticity and auto-correlation consistent covariance matrix. Econometrica 55: 703-708.
48. Nicholson, S., P. M. Danzon, and J. McCullough. 2003. Biotech-pharmaceutical alliances as a signal of asset and firm quality. NBER Working Paper 9007. Cambridge, MA: National Bureau of Economic Research.
49. Purnanandam, A. K., and B. Swaminathan. 2004. Are IPOs really underpriced? Review of Financial Studies 17(3): 811-848.
50. Ritter, J. R. 1991. The long run performance of initial public offerings. Journal of Finance 46: 3-28.
51. _, and T. Loughran. 1995. The new issues puzzle. Journal of Finance 50: 23-51.
52. _. 2000. The seven percent solution. Journal of Finance 55: 1105-1131.
53. _, and T. Loughran. 2002. Why don't issuers get upset about leaving money on the table in IPOs? Review of Financial Studies 15: 413-443.
54. Robinson, D. T., and T. Stuart. 2002. Contractual, relational, and equity-based control in biotech strategic alliances. Working paper, Duke University.
55. Sahlman, W. A. 1990. The structure and governance of venture capital organizations. Journal of Financial Economics 27: 473-521.
56. Seppä, T. J. 2003. Essays on the valuation and syndication of venture capital investments. Ph.D. dissertation, Helsinki University of Technology.
57. Shiller, R. 1990. Speculative prices and popular models. Journal of Economic Perspectives 4: 55-65.
58. Skinner, D. 1993. The investment opportunity set and accounting procedure choice: Preliminary evidence. Journal of Accounting & Economics 16: 407-445.
59. Smith, C. W., and R. L. Watts. 1992. The investment opportunity set and corporate financing, dividends, and compensation policies. Journal of Financial Economics 32: 262-292.
60. Smith, K. G., T. R. Mitchell, and C. E. Summer. 1985. Top level management priorities in different stages of the organizational life cycle. Academy of Management Journal 28: 729-820.
61. Stuart, T. E., H. Hoang, and R. C. Hybels. 1999. Interorganizational endorsements and the performance of entrepreneurial ventures. Administrative Science Quarterly 44: 315-349.
62. Trueman, B., F. Wong, and X-J. Zhang. 2000. The eyeballs have it: Searching for the value in Internet stocks. Journal of Accounting Research 38 (Supplement): 137-162.
63. Wong, A. 2002. Angel finance: The other venture capital. Working paper, University of Chicago.
64. Wright, M., and K. Robbie. 1998. Venture capital and private equity: A review and synthesis. Journal of Business Finance & Accounting 25 (5) & (6): 521-570.
65. Ye, J., and M. Finn. 2000. Nonlinear accounting-based equity valuation models. Working paper, Baruch College.
66. Zhang, X-J. 2001. Accounting conservatism and the analysis of line items in earnings forecasting and equity valuation. Working paper, University of California, Berkeley.
67. Zucker, L. G., and M. R. Darby. 1996. Star scientists and institutional transformation: Patterns of invention and innovation in the formation of the biotechnology industry. Proceedings of the National Academy of Sciences 93 (23): 12709-12716.
68. _, _, and M. B. Brewer. 1998. Intellectual human capital and the birth of U.S. biotechnology enterprises. American Economic Review 88 (1): 290-306.